Loading provider…
Loading provider…
Hematology (Internal Medicine) Physician in Boston, MA
NPI: 1043308570Primary Practice Location
BETH ISRAEL DEACONESS MEDICAL CENTER
330 Brookline Ave, Boston, MA
Primary Employer
Lahey Clinic
bilh.org
HQ Phone
Get MD Arthur's Phone NumberMobile
Get MD Arthur's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 28 | 73 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 20 | 23 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 18 | 44 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 15 | 15 |
Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia.
Authors: Alexey Danilov, Olga Danilova, Jennifer Brown, Arthur Rabinowitz, Andreas Klein, Brigitte Huber
Publication Date: 2010-07-22
Authors: Chai, Wanxing, Chaudhry, Abrar, Rabinowitz, Arthur P
Journal: J Clin Apher
Publication Date: 2014-04-30
Lead Sponsor: AbbVie
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Venetoclax, DRUG: Dexamethasone, DRUG: Bortezomib, DRUG: Placebo for venetoclax
Lead Sponsor: AbbVie
Collaborators: Roche-Genentech
Intervention / Treatment: DRUG: Venetoclax, DRUG: Dexamethasone, DRUG: Pomalidomide
Lead Sponsor: AbbVie
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Rituximab, DRUG: ABT-199